Zero debt if the $200 million is allocated properly.
The sale of Synergy's assets, including all rights to TRULANCE® (plecanatide), dolcanatide and related intellectual property, is now expected to close on or about March 5, 2019 (DONE)
Could be a fresh start?.. time will tell..
My Due diligence will not be obliterated 4 legalis proposita.